Frontlight ResearchEarly access
Trial site
CHU de Bordeaux, Hôpital Saint-André
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Melanoma3 trials
- Alopecia areata1 trial
- Bladder cancer1 trial
- Brain metastases1 trial
- Graves' disease1 trial
- High blood pressure1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Sickle cell disease1 trial
- Sjögren's disease1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed4 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Nantes University Hospital2 trials
- University Hospital, Bordeaux2 trials
- Amgen1 trial
- Assistance Publique - Hôpitaux de Paris1 trial
- Gustave Roussy, Cancer Campus, Grand Paris1 trial
- and 5 more
Running trials
Not yet recruiting
Recruiting
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
Recruiting
Neo-adjuvant Immunotherapy in Patients With Localized Melanoma
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma2 recruiting
- Brain metastases1 recruiting
- High blood pressure1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Sickle cell disease1 recruiting
Closed trials
Completed
Completed
Completed
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026